Literature DB >> 17185453

Positive benefit of postnatal treatment in congenital toxoplasmosis.

J E Gomez-Marin, A delaTorre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17185453      PMCID： PMC2083129     

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  5 in total

1.  Newborn screening for congenital toxoplasmosis: feasible, but benefits are not established.

Authors:  R Gilbert; C Dezateux
Journal:  Arch Dis Child       Date:  2006-08       Impact factor: 3.791

2.  Clinical validation of a western blot assay for congenital toxoplasmosis and newborn screening in a hospital in Armenia (Quindio) Colombia.

Authors:  Carolina Gallego-Marín; Ana Carolina Henao; Jorge Enrique Gómez-Marín
Journal:  J Trop Pediatr       Date:  2005-07-13       Impact factor: 1.165

3.  The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999-2002.

Authors:  D R Schmidt; B Hogh; O Andersen; J Fuchs; H Fledelius; E Petersen
Journal:  Arch Dis Child       Date:  2006-08       Impact factor: 3.791

4.  Outcome of treatment for congenital toxoplasmosis, 1981-2004: the National Collaborative Chicago-Based, Congenital Toxoplasmosis Study.

Authors:  Rima McLeod; Kenneth Boyer; Theodore Karrison; Kristen Kasza; Charles Swisher; Nancy Roizen; Jessica Jalbrzikowski; Jack Remington; Peter Heydemann; A Gwendolyn Noble; Marilyn Mets; Ellen Holfels; Shawn Withers; Paul Latkany; Paul Meier
Journal:  Clin Infect Dis       Date:  2006-04-11       Impact factor: 9.079

5.  Long-term ocular prognosis in 327 children with congenital toxoplasmosis.

Authors:  Martine Wallon; Laurent Kodjikian; Christine Binquet; Justus Garweg; Jacques Fleury; Catherine Quantin; François Peyron
Journal:  Pediatrics       Date:  2004-06       Impact factor: 7.124
  5 in total
  2 in total

1.  Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.

Authors:  Eileen Stillwaggon; Christopher S Carrier; Mari Sautter; Rima McLeod
Journal:  PLoS Negl Trop Dis       Date:  2011-09-27

2.  Novel triazine JPC-2067-B inhibits Toxoplasma gondii in vitro and in vivo.

Authors:  Ernest J Mui; Guy A Schiehser; Wilbur K Milhous; Honghue Hsu; Craig W Roberts; Michael Kirisits; Stephen Muench; David Rice; J P Dubey; Joseph W Fowble; Pradipsinh K Rathod; Sherry F Queener; Susan R Liu; David P Jacobus; Rima McLeod
Journal:  PLoS Negl Trop Dis       Date:  2008-03-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.